Galectin-3C: Human Lectin for Treatment of Cancer-Reference-Cited by-同舟云学术

Galectin-3C: Human Lectin for Treatment of Cancer

Published:2012-01 Issue: Volume: Page:195-232
ISSN:0097-6156
Container-title:ACS Symposium Series
language:
Short-container-title:

Author:

Jarvis Gary A.¹²³⁴⁵,Mirandola Leonardo¹²³⁴⁵,Yuefei Yu¹²³⁴⁵,Cobos Everardo¹²³⁴⁵,Chiriva-Internati Maurizio¹²³⁴⁵,John Constance M.¹²³⁴⁵

Affiliation:

1. Center for Immunochemistry, Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, California 94121

2. Department of Laboratory Medicine, University of California, San Francisco, California 94143

3. Department of Internal Medicine at the Division of Hematology & Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, Texas 79415

4. Laura W. Bush Institute for Women’s Health and Center for Women’s Health and Gender-Based Medicine, Amarillo, Texas 79106

5. MandalMed, 665 3rd Street, Suite 250, San Francisco, California 94107

Publisher

American Chemical Society

Link

https://pubs.acs.org/doi/pdf/10.1021/bk-2012-1115.ch012

Reference223 articles.

1. Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma

2. Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response

3. Tyrosine-phosphorylated Galectin-3 Protein Is Resistant to Prostate-specific Antigen (PSA) Cleavage

4. Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ¹⁹F Fast Magic-Angle Spinning NMR Spectroscopy on Microcrystalline Complexes of Fluorinated Ligands and the Carbohydrate Recognition Domain of Galectin-3;Biochemistry;2024-07-15

2. Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades;Cardiovascular Research;2023-08-21